IPSC — Century Therapeutics Share News
0.000.00%
Last trade - 00:00- $264.37m
- $144.66m
- $109.16m
U.S. STOCKS ON THE MOVE-Tesla, Dell, Citi Trends, Tilly's, Century Therapeutics
U.S. STOCKS ON THE MOVE-Bank stocks, Robinhood, Cardinal Health, Infosys, Zynga
Century Therapeutics rises on collaboration with Bristol Myers
Brief: Century Therapeutics, Bristol Myers Enter Collaboration To Develop IPSC-Derived Allogeneic Cell Therapies
Brief: Century Therapeutics Announces Presentation Of Data At 63Rd American Society Of Hematology Annual Meeting And Provides Pipeline Updates
Brief: Century Therapeutics Reports Q3 2021 Financial Results
Brief: Century Therapeutics Inc And Outpace Bio Enter Research Collaboration In Car Engineering
Brief: Century Therapeutics Announces Its Addition To The Russell 2000 Index
Century Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Century Therapeutics Reports Q2 Loss Per Share Of $1.93
U.S. RESEARCH ROUNDUP- Angel Oak Mortgage, Century Therapeutics, Zoetis
Brief: Century Therapeutics Shares Open 2.5% Below IPO Price In Nasdaq Debut
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM